Galvita's core activity is the development and manufacture of galenics, i.e. pharmaceutical formulations and active ingredients for the pharmaceutical industry.
AI-generated
Offering
Products & services
Industry:Research & DevelopmentPharmaceutical Industry
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Innovative oral drug delivery platform with TIP microcapsules for orally disintegrating tablets, rapid disintegration, taste masking, smaller tablet sizes and water-free ingestion.
Early formulation screening
Early formulation screening for APIs using the TIP platform, including project assessment, solvent screening, drug loading, solid-state characterization, and compressibility and disintegration testing.
GMP manufacturing of clinical trial material
GMP manufacturing of clinical trial material for clinical studies, including support for manufacturing study sample tablets based on TIP technology.
Clinical studies and bioequivalence studies
Design and execution of clinical studies as well as bioequivalence and efficacy studies for TIP-based products, including assessment of pharmacokinetics and bioavailability.
R&D services for dosage forms
Research and development services along the value chain, from early formulation and feasibility studies to scale-up, IP and regulatory support.
Knowledge
No knowledge articles yet
Once Galvita AG has claimed this profile, we'll publish editorial articles and case studies here together.